D. van Zeben

5.1k citations

41 papers · 3.9k indexed · 2 hit papers · h-index 24

Impact in

Rheumatology top 0.1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research

Papers in

Rheumatology 39
- Rheumatoid Arthritis Research and Therapies 38
- Systemic Lupus Erythematosus Research 25
- Spondyloarthritis Studies and Treatments 3
Hematology 13
- Autoimmune and Inflammatory Disorders Research 12

Co-authors: Ben A. C. Dijkmans F. C. Breedveld A. H. Zwinderman Johanna M W Hazes Jeska K de Vries‐Bouwstra P. J. S. M. Kerstens Cornelia F Allaart A. Gerards
Journals: Annals of the Rheumatic Diseases (12 papers)Lara D. Veeken (6 papers)Atherosclerosis (2 papers)Scandinavian Journal of Rheumatology (2 papers)Annals of Internal Medicine (1 paper)
Partner nations: Netherlands Gabon United Kingdom

In The Last Decade

D. van Zeben

41 papers receiving 3.7k citations

Hit Papers

align trajectories log scale

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial 2005 · 1.1k citations

Peers

Countries citing papers authored by D. van Zeben

Since Specialization

Citations

This map shows the geographic impact of D. van Zeben's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. van Zeben with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. van Zeben more than expected).

Fields of papers citing papers by D. van Zeben

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. van Zeben. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. van Zeben. The network helps show where D. van Zeben may publish in the future.

Co-authors

The 25 scholars most cited alongside D. van Zeben, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D. van Zeben Line = papers co-authored together D. van Zeben links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial Annals of the Rheumatic Diseases ·T. Martijn Kuijper, Jolanda J. Luime, Pascal H P de Jong, A. Gerards, D. van Zeben, Ilja Tchetverikov, P. B. J. de Sonnaville, M V van Krugten, Bernard Grillet, Johanna M. W. Hazes, A. Weel	2016	28
2	Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis Lara D. Veeken ·Lucas Brien, D. van Zeben, Boudewijn Klop, Gert‐Jan M. van de Geijn, Tilmann Gütt, Shahji Deshmukh, Marijke A. de Vries, M. Hazes, Erwin Birnie, Manuel Castro Cabezas	2016	53
3	Best cost-effectiveness and worker productivity with initial triple DMARD therapy compared with methotrexate monotherapy in early rheumatoid arthritis: cost–utility analysis of the tREACH trial Lara D. Veeken ·Pascal H P de Jong, Johanna M. W. Hazes, Leander R. Buisman, P J Barendregt, D. van Zeben, Mohammad Yoga Adji Pangestu, Andreas Gerards, Pierre Béteille, P. B. J. de Sonnaville, Bernard Grillet, Jolanda J. Luime, A. Weel	2016	14
4	Adherence to cardiovascular prevention strategies in patients with rheumatoid arthritis Scandinavian Journal of Rheumatology ·Lucas Brien, Jan Zijlmans, D. van Zeben, Boudewijn Klop, van Willem Oeveren, R. Santo, M. Hazes, Erwin Birnie, Manuel Castro Cabezas	2015	13
5	Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis? Lara D. Veeken ·Myrthe van der Ven, Е М Локтин, Jolanda J. Luime, Andreas Gerards, P J Barendregt, D. van Zeben, 敏子森脇, P. B. J. de Sonnaville, Bernard Grillet, Johanna M. W. Hazes	2015	6
6	Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial Annals of the Rheumatic Diseases ·北京大学艺术学院, J. M. W. Hazes, Ana Michelle Dominguez Rodriguez, Martijn Huisman, D. van Zeben, Mohammad Yoga Adji Pangestu, A. Gerards, 敏子森脇, M.S. Figueiredo, M V van Krugten, J. Luime, A. Weel	2014	92
7	Cardiovascular risk in rheumatoid arthritis: How to lower the risk? Atherosclerosis ·Lucas Brien, Boudewijn Klop, D. van Zeben, Johanna M W Hazes, Manuel Castro Cabezas	2013	50
8	Induction therapy with a combination of DMARDs is better than methotrexate monotherapy: first results of the tREACH trial Annals of the Rheumatic Diseases ·北京大学艺术学院, Johanna M. W. Hazes, P J Barendregt, Martijn Huisman, D. van Zeben, Mohammad Yoga Adji Pangestu, A. Gerards, Pierre Béteille, M.S. Figueiredo, Bernard Grillet, Jolanda J. Luime, A. Weel	2012	97
9	Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH) Annals of the Rheumatic Diseases ·Е М Локтин, Jolanda J. Luime, D. van Zeben, A.M. Huisman, A. Weel, P J Barendregt, Johanna M W Hazes	2011	55
10	Use of risk stratification to target therapies in patients with recent onset arthritis; design of a prospective randomized multicenter controlled trial BMC Musculoskeletal Disorders ·Susanne Claessen, Johanna M. W. Hazes, Margriet Huisman, D. van Zeben, Jolanda J. Luime, A. Weel	2009	43
11	Implementation of a physical activity intervention for people with rheumatoid arthritis: A case study Musculoskeletal Care ·M. van den Berg, Florus van der Giesen, D. van Zeben, J.H.L.M. van Groenendael, Patrick Seys, T. P. M. Vliet Vlieland	2008	10
12	Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis Annals of the Rheumatic Diseases ·S M van der Kooij, Saskia le Cessie, Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, D. van Zeben, P. J. S. M. Kerstens, Johanna M W Hazes, Dirkjan van Schaardenburg, F. C. Breedveld, Ben A. C. Dijkmans, Cornelia F Allaart	2008	92
13	Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score Annals of the Rheumatic Diseases ·S M van der Kooij, Jeska K de Vries‐Bouwstra, Y P M Goekoop-Ruiterman, D. van Zeben, P. J. S. M. Kerstens, A. Gerards, J.H.L.M. van Groenendael, Johanna M. W. Hazes, FC Breedveld, Kwang Duk Kim, Ben A. C. Dijkmans	2007	71
14	Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial Arthritis & Rheumatism ·Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra, Cornelia F Allaart, D. van Zeben, P. J. S. M. Kerstens, Johanna M W Hazes, A. H. Zwinderman, H. K. Ronday, K. H. Han, M L Westedt, A. Gerards, J.H.L.M. van Groenendael, Willem F. Lems, M V van Krugten, F. C. Breedveld, Ben A. C. Dijkmans Hit paper breakdown →	2005	1104
15	Long-term course and outcome of functional capacity in rheumatoid arthritis: The effect of disease activity and radiologic damage over time Arthritis & Rheumatism ·K.W. Drossaers-Bakker, Fathur Rahman Alfajri, D. van Zeben, Aeilko H. Zwinderman, FC Breedveld, Johanna M. W. Hazes	1999	324
16	Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis The Lancet ·Maarten Boers, Arco C. Verhoeven, H. M. Markusse, M A van de Laar, René Westhovens, J. Christiaan van Denderen, D. van Zeben, Ben A. C. Dijkmans, André J. Peeters, Piet Jacobs, H. R. Van Den Brink, Hubert J. A. Schouten, Désirée van der Heijde, Annelies Boonen, Sjef van der Linden Hit paper breakdown →	1997	800
17	EARLY AGALACTOSYLATION OF IgG IS ASSOCIATED WITH A MORE PROGRESSIVE DISEASE COURSE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF A FOLLOW-UP STUDY Lara D. Veeken ·D. van Zeben, G.A.W. Rook, J. M. W. Hazes, A. H. Zwinderman, Haixin Deng, Rebecca De Lorenzo, T. W. Rademacher, F. C. Breedveld	1994	81
18	Association of HLA–DR4 with a more progressive disease course in patients with rheumatoid arthritis. Results of a followup study Arthritis & Rheumatism ·D. van Zeben, John Paul LeBlanc, F.R. Bridge, A. Cats, Geziena M. Th. Schreuder, J. D‘Amaro, Ferdinand C. Breedveld	1991	141
19	Evaluation of microcytosis using serum ferritin and red blood cell distribution width European Journal Of Haematology ·D. van Zeben, R. Bieger, Mahfuza Anika, Ad Castel, Jo Hermans	1990	76
20	Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive use Arthritis & Rheumatism ·D. van Zeben, Johanna M W Hazes, Jan P. Vandenbroucke, Ben A. C. Dijkmans, A. Cats	1990	28

About D. van Zeben

D. van Zeben is a scholar working on Rheumatology, Hematology, Genetics, Hepatology and Pathology and Forensic Medicine, having authored 41 papers that have together received 3.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (38 papers), Systemic Lupus Erythematosus Research (25 papers), Autoimmune and Inflammatory Disorders Research (12 papers), Lymphoma Diagnosis and Treatment (8 papers), Chronic Lymphocytic Leukemia Research (7 papers), Hepatitis C virus research (4 papers), Spondyloarthritis Studies and Treatments (3 papers) and Lymphadenopathy Diagnosis and Analysis (2 papers). The work is most often cited by research in Rheumatology (3.3k citations), Hematology (1.4k citations), Genetics (681 citations), Pathology and Forensic Medicine (494 citations) and Immunology (571 citations). D. van Zeben has collaborated with scholars based in Netherlands, Gabon and United Kingdom. Frequent co-authors include Ben A. C. Dijkmans, F. C. Breedveld, A. H. Zwinderman, Johanna M W Hazes, Jeska K de Vries‐Bouwstra, P. J. S. M. Kerstens, Cornelia F Allaart, A. Gerards, Y P M Goekoop-Ruiterman and M V van Krugten. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, Atherosclerosis, Scandinavian Journal of Rheumatology and Annals of Internal Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact